Results

Total Results: over 10,000 records

Showing results for "risk".

  1. pcmh.ahrq.gov/patient-safety/resources/learning-lab/improving-safety-diagnosis-long-desc.html
    February 01, 2024 - In this risk score, X n represents baseline risk factors and in-hospital clinical factors, as well as … The high-risk cohorts included cases of patients who were transferred to the ICU after 24 hours, died … with preimplementation period (16.5 vs. 20.9, OR 0.75 [95% CI 0.43-1.29], p=0.29), or a 25 percent relativerisk reduction in overall DE. 1 In postimplementation analysis, researchers found that relative risk … reductions in DE were greater in patients in the high-risk cohort.
  2. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0243-section5.pdf
    December 18, 2014 - III National Cancer Institute 2012, Radiation risks and pediatric computed tomography (CT): A guide … http://www.cancer.gov/cance rtopics/causes/radiation/radia tion-risks-pediatric-CT. … in the context of III Berrington de González A, Mahesh M, Kim DP et al., Projected cancer risks … /cancertopics/causes/radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes … /radiation/radiation-risks-pediatric-CT http://www.cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT
  3. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication
    December 15, 2010 - Thus, primary analyses estimated relative risk for falling by using random-effects models 20-21 . … After 12 months, the relative risk for falling between the intervention group and usual care was 0.86 … affect the overall statistical significance for comprehensive interventions (relative risk, 0.88 [CI, … statistically significant (relative risk, 0.83 [CI, 0.71 to 0.97]). … The overall pooled relative risk for falling (n=6,322) was 0.94 (95% CI, 0.87 to 1.02), with moderate
  4. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication-2012
    December 15, 2010 - Thus, primary analyses estimated relative risk for falling by using random-effects models 20-21 . … After 12 months, the relative risk for falling between the intervention group and usual care was 0.86 … affect the overall statistical significance for comprehensive interventions (relative risk, 0.88 [CI, … statistically significant (relative risk, 0.83 [CI, 0.71 to 0.97]). … The overall pooled relative risk for falling (n=6,322) was 0.94 (95% CI, 0.87 to 1.02), with moderate
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
    March 10, 2010 - Introduction Women need to understand what their own risks are of death as a result of breast cancer … for that subgroup, or difference in relative risk. … We agree, sorting out baseline risks from elevated relative risks is confusing. … We have included relative risk estimates for each subgroup in the text when they are calculated. … (older age) versus relative risk of treatment.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
    March 10, 2010 - Introduction Women need to understand what their own risks are of death as a result of breast cancer … for that subgroup, or difference in relative risk. … We agree, sorting out baseline risks from elevated relative risks is confusing. … We have included relative risk estimates for each subgroup in the text when they are calculated. … (older age) versus relative risk of treatment.
  7. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
    February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk … to address this risk. 2. … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients … DeFelippis AP, Young R. (2016) Estimating Longitudinal Risks and Benefits from Cardiovascular Preventive … 2017 at: http://www.acc.org/latest-in-cardiology/articles/2016/11/04/08/56/estimating-longitudinal- risks-and-benefits-from-cv-preventive-therapies
  8. www.ahrq.gov/sites/default/files/2025-02/platt-report.pdf
    January 01, 2025 - Hospitals reporting higher SSI risks will receive lower reimbursement. … In general, deep incisional and organ/space SSIs are associated with a two- to four-fold relative risk … of death during the post- operative hospitalization and a five- to six-fold relative risk of readmission … For modeling risks, each hospital’s risk in a given year was assessed as a predictor of its risk in … The net result for the SSI risks was the proportion of the following year’s risk that is the result
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/q_zxLD9JZFGoSPCrEHNk2g
    June 11, 2019 - of a composite outcome of mortality, AIDS-defining events, or serious non-AIDS events (relative riskRelative risks (RRs) were calculated based on reported event rates, to calculate absolute risk differences … (95% CI, 0.04-5.02) NR Abbreviations: HPTN, HIV Prevention Trials Network; NR, not reported; RR, relative … 95% CI, 0.94-1.25]) Some inconsistency between RCT and observational data regarding cardiovascular risks … rate ratio; KQ, key question; NA, not applicable; OR, odds ratio; RCT, randomized clinical trial; RR, relative
  10. effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
    April 01, 2020 - nonopioids alone, and opioids plus nonopioids versus opioids alone at short-term followup.16 Pooled relative … of overdose; risks were higher at increased gabapentinoid doses (SOE: low). … of overdose; risks were higher at increased gabapentinoid doses (SOE: low). … and risks related to opioid use disorder, was lacking. … Annual Surveillance Report of Drug-Related Risks and Outcomes--United States, 2017.
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
    April 01, 2020 - nonopioids alone, and opioids plus nonopioids versus opioids alone at short-term followup.16 Pooled relative … of overdose; risks were higher at increased gabapentinoid doses (SOE: low). … of overdose; risks were higher at increased gabapentinoid doses (SOE: low). … and risks related to opioid use disorder, was lacking. … Annual Surveillance Report of Drug-Related Risks and Outcomes--United States, 2017.
  12. effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
    May 01, 2021 - There continues to be no evidence of increased risk of adverse events for vaccines currently recommended … We documented the observed rates of adverse events and assessed the relative risks between vaccinated … some observational studies showed increased risk) Moderate: No evidence of increased risk of asthma … or to definitively exclude a risk of such adverse events. … Potential risks of rare adverse events should be weighed against the protective benefits that vaccines
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-244-safety-vaccines-update-evidence-summary.pdf
    May 01, 2021 - There continues to be no evidence of increased risk of adverse events for vaccines currently recommended … We documented the observed rates of adverse events and assessed the relative risks between vaccinated … some observational studies showed increased risk) Moderate: No evidence of increased risk of asthma … or to definitively exclude a risk of such adverse events. … Potential risks of rare adverse events should be weighed against the protective benefits that vaccines
  14. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk … CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk … to address this risk. 2. … DeFelippis AP, Young R. (2016) Estimating Longitudinal Risks and Benefits from Cardiovascular Preventive … 2017 at: http://www.acc.org/latest-in-cardiology/articles/2016/11/04/08/56/estimating-longitudinal- risks-and-benefits-from-cv-preventive-therapies
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
    February 01, 2018 - individual trials considered in meta-analyses - More likely to be consistent even with differing baseline risks … interpretable than OR Odds Ratio (OR) - More likely to be consistent even with differing baseline risks … considered in meta-analyses - Not easily interpretable - Can be misleading when interpreted like relativerisks - Widespread use in meta-analyses may be because of convenience and history rather than an assessment … differ in baseline risk
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-2.pdf
    February 01, 2018 - individual trials considered in meta-analyses - More likely to be consistent even with differing baseline risks … interpretable than OR Odds Ratio (OR) - More likely to be consistent even with differing baseline risks … considered in meta-analyses - Not easily interpretable - Can be misleading when interpreted like relativerisks - Widespread use in meta-analyses may be because of convenience and history rather than an assessment … differ in baseline risk
  17. digital.ahrq.gov/sites/default/files/docs/page/modeling-risk-reduction-interventions-for-patients-with-type-2-diabetes-mellitus.pdf
    June 03, 2010 - failure  Retinopathy  Blindness  Foot ulcers  Amputation Challenges Variation in calculated risks … Factors P ro ba bi lit y Low Risk High Risk 20 Year Risk of Renal Failure 0 10 20 30 40 … Factors P ro ba bi lit y Low Risk High Risk 20 Year Risk of Blindness 0 0.2 0.4 0.6 0.8 … Factors P ro ba bi lit y Low Risk High Risk 20 Year Risk of Amputation 0 0.1 0.2 0.3 0.4 … Absolute Risk Reduction = Risk X Relative Risk Reduction Each intervention reduces risk, so ARR gets
  18. effectivehealthcare-admin.ahrq.gov/products/gestational-diabetes-screening-diagnosis/research-protocol
    December 01, 2019 - complications, psychological issues, and an increased likelihood of developing diabetes later in life. 6 Risks … This will be done using the Mantel-Haenszel method for relative risks and the inverse variance method … For dichotomous outcomes, we will compute relative risks to estimate between-group differences. … correction factor of 0.5 will be added to each cell of the 2x2 table in order to obtain estimates of the relativerisk.
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - and nonselective) appear to be associated with increased risk of serious CV risks. … clear association between longer duration of therapy with COX-2 selective NSAIDs and increase in the relative … However, because the event rates increases in older patients, even if the relative risk estimates are … There was insufficient evidence to evaluate comparative risks of GI bleeding or CV events. … anti-inflammatory drug; OR = odds ratio; PPI = proton pump inhibitor; PUD = peptic ulcer disease; RR = relative
  20. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - and nonselective) appear to be associated with increased risk of serious CV risks. … clear association between longer duration of therapy with COX-2 selective NSAIDs and increase in the relative … However, because the event rates increases in older patients, even if the relative risk estimates are … There was insufficient evidence to evaluate comparative risks of GI bleeding or CV events. … anti-inflammatory drug; OR = odds ratio; PPI = proton pump inhibitor; PUD = peptic ulcer disease; RR = relative